Figure 4
Figure 4. Kaplan-Meier estimates of OS for FLT3-ITD−positive patients in all integrated risk groups by CD25 status. Data are shown for FLT3-ITD–positive/CD25NEG (CD25−; solid line, n = 63) vs FLT3-ITD−positive/CD25POS patients (CD25+; dashed line, n = 57).

Kaplan-Meier estimates of OS for FLT3-ITD−positive patients in all integrated risk groups by CD25 status. Data are shown for FLT3-ITD–positive/CD25NEG (CD25−; solid line, n = 63) vs FLT3-ITD−positive/CD25POS patients (CD25+; dashed line, n = 57).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal